Douglass Hanly Moir Pathology
www.dhm.com.auDHM is an established and well-respected pathology practice, offering comprehensive, high-quality pathology services for clinicians and healthcare professionals, private hospitals and nursing homes in NSW and north-west Victoria. We are medically managed by pathologists and a select and highly qualified team of scientific staff and senior management. Our practice is managed by doctors for doctors. Our CEO, Dr Colin Goldschmidt, is a pathologist. All department directors are pathologists, and pathologists are represented at all levels of management. Our executive and senior management staff and pathologists encourage clinicians to contact them for information, consultation, support or advice at any time. Our liaison and regional managers are available to assist clinicians and their staff with the practicalities of using our services. Douglass Hanly Moir Pathology's success is driven by the innate understanding that Medical Leadership facilitates the highest standards of professional and operational excellence for the doctors and patients that we serve. Medical Leadership is enshrined in our culture, reflecting our deep understanding of the special complexities, obligations and privileges of medical practice. Our Medical Leadership philosophy honours the following ideals of medical practice: – Our highest priority is patients and their wellbeing – Our actions, behaviours and business decisions are always focused on supporting clinicians and good medical practice – We strive to achieve the highest standards of quality and service excellence – We are committed to supporting and being part of the medical communities we serve – We recognise and support the importance of medical education, research and professional advocacy – Our commitment to Medical Leadership is reflected in our organisational structure
Read moreDHM is an established and well-respected pathology practice, offering comprehensive, high-quality pathology services for clinicians and healthcare professionals, private hospitals and nursing homes in NSW and north-west Victoria. We are medically managed by pathologists and a select and highly qualified team of scientific staff and senior management. Our practice is managed by doctors for doctors. Our CEO, Dr Colin Goldschmidt, is a pathologist. All department directors are pathologists, and pathologists are represented at all levels of management. Our executive and senior management staff and pathologists encourage clinicians to contact them for information, consultation, support or advice at any time. Our liaison and regional managers are available to assist clinicians and their staff with the practicalities of using our services. Douglass Hanly Moir Pathology's success is driven by the innate understanding that Medical Leadership facilitates the highest standards of professional and operational excellence for the doctors and patients that we serve. Medical Leadership is enshrined in our culture, reflecting our deep understanding of the special complexities, obligations and privileges of medical practice. Our Medical Leadership philosophy honours the following ideals of medical practice: – Our highest priority is patients and their wellbeing – Our actions, behaviours and business decisions are always focused on supporting clinicians and good medical practice – We strive to achieve the highest standards of quality and service excellence – We are committed to supporting and being part of the medical communities we serve – We recognise and support the importance of medical education, research and professional advocacy – Our commitment to Medical Leadership is reflected in our organisational structure
Read moreCountry
Industry
Employees
1001-5000
Estimated Revenue
$250,000,000 to $500,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Maintenance Manager
Email ****** @****.comPhone (***) ****-****Lab Manager
Email ****** @****.comPhone (***) ****-****Phlebotomist
Email ****** @****.comPhone (***) ****-****Pathology
Email ****** @****.comPhone (***) ****-****
Technologies
(13)